Analysen von Keyur Parekh
| 12.05.16 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 10.05.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 03.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.04.16 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 12.04.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.03.16 | GSK buy | Goldman Sachs Group Inc. | |
| 14.03.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 01.03.16 | Roche buy | Goldman Sachs Group Inc. | |
| 01.03.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.02.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 12.01.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Merck Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 07.01.16 | GSK buy | Goldman Sachs Group Inc. | |
| 07.01.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.12.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 09.12.15 | Merck Neutral | Goldman Sachs Group Inc. | |
| 04.12.15 | Roche buy | Goldman Sachs Group Inc. | |
| 04.12.15 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.11.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.11.15 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.11.15 | GSK buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 18.11.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 17.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.11.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 06.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 06.11.15 | GSK buy | Goldman Sachs Group Inc. | |
| 05.11.15 | GSK buy | Goldman Sachs Group Inc. | |
| 02.11.15 | GSK buy | Goldman Sachs Group Inc. | |
| 28.10.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 28.10.15 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.10.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 21.10.15 | GSK buy | Goldman Sachs Group Inc. | |